Dapagliflozin reduces thrombin generation and platelet activation: implications for cardiovascular risk reduction in type 2 diabetes mellitus
2021 · Diabetologia · 44 citations
https://doi.org/10.1007/s00125-021-05498-0
I
Irena Krüger
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
14
Papers
384
Citations
9
h-index
9
i10-index
Irena Krüger is an academic researcher from Dana-Farber Cancer Institute. The author has contributed to research in topics: Platelet Disorders and Treatments & Aortic aneurysm repair treatments & Antiplatelet Therapy and Cardiovascular Diseases. The author has an h-index of 9, co-authored 12 publications.
Papers by this author
worksCD45-PET is a robust, non-invasive tool for imaging inflammation
2025 · Nature · 30 citations
https://doi.org/10.1038/s41586-024-08441-6
GP VI–Mediated Platelet Activation and Procoagulant Activity Aggravate Inflammation and Aortic Wall Remodeling in Abdominal Aortic Aneurysm
2024 · Arteriosclerosis Thrombosis and Vascular Biology · 22 citations
https://doi.org/10.1161/atvbaha.123.320615
Phospholipase D1 regulation of TNF-alpha protects against responses to LPS
2018 · Scientific Reports · 19 citations
https://doi.org/10.1038/s41598-018-28331-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat